Rizatriptan 10 MG RPD in the Treatment of Acute Migraine

Exclusion Criteria

• •Contraindication to triptans or Rizatriptan according to medical information sheet.
• •Patient has a history or clinical evidence of ischemic heart disease (e.g., angina pectoris of any type, history of myocardial infarction or documented silent ischemia) or symptoms or findings consistent with ischemic heart disease, coronary artery vasospasm (including Prinzmetal's variant angina), or other significant underlying cardiovascular disease. Patient has uncontrolled hypertension. Patient has either demonstrated hypersensitivity to or experienced a serious adverse event in response to Rizatriptan or any of its inactive ingredients.
• •History of treatment failure for at least one triptan for the treatment of acute migraine attacks.
• •Any other headache, except tension type headache on 5 or less days a month within three months prior to screening.
• •A history of drug induced headache, medication overuse headache or any other addiction.
• •Any history of allergic hypersensitivity or poor tolerance to any components of the preparations used in this trial.
• •Females of childbearing potential not using reliable means of birth control, pregnant or lactating females or expected/ planned pregnancy.
• •Participation (planned or current) in any investigational drug or device trial within the previous 30 days prior to screening visit.
• •Inability to understand the trial procedures, and thus inability to give informed consent.
• •History of allergy to sulfa drugs.